Share Price and Basic Stock Data
Last Updated: November 19, 2025, 11:34 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bilcare Ltd operates within the packaging and containers industry, focusing on providing innovative packaging solutions. The company’s reported sales for the fiscal year ending March 2023 stood at ₹982 Cr, reflecting a decline from ₹1,827 Cr in FY 2020, which highlights a significant contraction over the past few years. The sales for the latest quarter of September 2023 were ₹189.92 Cr, showcasing a slight recovery from ₹182.25 Cr in June 2023. However, there remains a notable drop from earlier quarterly sales figures, such as ₹254.03 Cr in September 2022. The overall trend indicates challenges in maintaining revenue levels, likely due to heightened competition and market conditions affecting demand. Additionally, the trailing twelve months (TTM) revenue was reported at ₹780 Cr, which is lower than previous years, signaling ongoing difficulties in achieving sustainable growth.
Profitability and Efficiency Metrics
Bilcare Ltd’s profitability metrics reflect a challenging operational environment. The operating profit margin (OPM) for the fiscal year ending March 2025 is reported at 3.81%, indicating a decline from 7.34% in March 2014. This reduction highlights inefficiencies and rising costs impacting profitability. The company recorded a net profit of ₹50 Cr in FY 2023, a stark contrast to the net loss of ₹59 Cr projected for FY 2024. The interest coverage ratio (ICR) stands at 0.76x, suggesting that the company generates insufficient earnings to cover interest expenses. Furthermore, the return on equity (ROE) is reported at 5.58%, which is relatively low compared to industry standards, indicating that shareholder returns are constrained. Overall, Bilcare’s profitability remains under pressure as reflected in its declining margins and profitability ratios.
Balance Sheet Strength and Financial Ratios
Bilcare Ltd’s balance sheet reveals several areas of concern. The company recorded total borrowings of ₹0 Cr, indicating a conservative approach to leveraging; however, this could also suggest limited growth funding. The current ratio is reported at 1.01x, which is marginally above the industry norm, indicating adequate short-term liquidity to cover liabilities. However, the total debt to equity ratio is at 1.43x, suggesting a reliance on debt financing relative to equity, which could pose risks in adverse market conditions. The book value per share is ₹199.21, yet the price to book value ratio stands at 0.46x, indicating that the stock may be undervalued relative to its net asset value. Additionally, the company has shown a decreasing trend in return on capital employed (ROCE), which is 1.10%, further emphasizing the need for improved capital efficiency.
Shareholding Pattern and Investor Confidence
Bilcare Ltd’s shareholding pattern reflects a stable but concentrated ownership structure. Promoters hold 30.01% of the equity, which has remained consistent over multiple quarters, suggesting a commitment to the company. Foreign institutional investors (FIIs) own a mere 0.04%, which indicates limited foreign interest and potentially raises concerns regarding investor confidence. The public holds 69.94% of the shares, reflecting a broad base of retail investors. However, the total number of shareholders has declined from 23,419 in December 2022 to 16,513 in March 2025, indicating a potential loss of investor interest or confidence in the company’s growth prospects. This trend may impact liquidity and market perception, particularly if the company does not demonstrate a clear path to profitability and growth.
Outlook, Risks, and Final Insight
Looking ahead, Bilcare Ltd faces both opportunities and challenges. Strengths include a stable promoter holding and a strong presence in the packaging sector, which could benefit from emerging trends in sustainable packaging. However, risks are pronounced, including declining revenue, low profitability margins, and a reduced number of shareholders, which may affect liquidity. The company must navigate these challenges to improve operational efficiency and return to growth. A focus on cost management, innovation in product offerings, and strengthening investor relations will be crucial. If Bilcare can successfully adapt to market demands and enhance profitability, it may regain investor confidence and improve its market position. Conversely, failure to address these issues could lead to further declines in financial performance and market valuation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bilcare Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 121 Cr. | 116 | 225/115 | 11.0 | 210 | 0.69 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 98.9 Cr. | 175 | 191/160 | 14.4 | 94.4 | 0.86 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 18.2 Cr. | 13.1 | 34.8/11.4 | 24.5 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 16.0 Cr. | 7.29 | 10.4/4.85 | 19.6 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 9,685 Cr. | 4,169 | 5,378/2,317 | 31.0 | 1,079 | 0.29 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 2,020.50 Cr | 354.08 | 50.22 | 189.19 | 0.32% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 255.69 | 248.13 | 254.03 | 245.86 | 233.59 | 182.25 | 189.92 | 174.94 | 200.07 | 194.14 | 201.74 | 198.13 | 194.03 |
| Expenses | 236.93 | 232.26 | 239.57 | 233.84 | 219.16 | 168.79 | 173.22 | 157.69 | 208.33 | 175.20 | 194.09 | 187.48 | 186.64 |
| Operating Profit | 18.76 | 15.87 | 14.46 | 12.02 | 14.43 | 13.46 | 16.70 | 17.25 | -8.26 | 18.94 | 7.65 | 10.65 | 7.39 |
| OPM % | 7.34% | 6.40% | 5.69% | 4.89% | 6.18% | 7.39% | 8.79% | 9.86% | -4.13% | 9.76% | 3.79% | 5.38% | 3.81% |
| Other Income | 5.13 | 2.68 | 9.61 | -6.46 | 231.29 | 2.75 | 0.56 | 3.76 | 8.82 | 3.74 | -6.02 | -6.47 | 21.16 |
| Interest | 16.95 | 15.82 | 16.44 | 16.36 | 11.38 | 19.00 | 19.66 | 20.54 | 22.59 | 20.85 | 23.68 | 19.48 | 18.49 |
| Depreciation | 9.45 | 9.43 | 9.44 | 9.64 | 9.30 | 10.50 | 10.48 | 10.57 | 13.40 | 11.52 | 11.04 | 11.74 | 11.58 |
| Profit before tax | -2.51 | -6.70 | -1.81 | -20.44 | 225.04 | -13.29 | -12.88 | -10.10 | -35.43 | -9.69 | -33.09 | -27.04 | -1.52 |
| Tax % | 38.25% | -11.49% | 59.67% | -5.87% | 65.22% | -1.13% | -5.36% | 34.06% | -44.48% | 55.01% | -9.55% | -39.90% | -431.58% |
| Net Profit | -3.47 | -5.93 | -2.89 | -19.24 | 78.28 | -13.14 | -12.19 | -13.54 | -19.67 | -15.02 | -29.93 | -16.25 | 5.04 |
| EPS in Rs | -2.48 | -2.84 | -2.42 | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 | 4.48 |
Last Updated: May 31, 2025, 6:42 am
Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 194.03 Cr.. The value appears to be declining and may need further review. It has decreased from 198.13 Cr. (Dec 2024) to 194.03 Cr., marking a decrease of 4.10 Cr..
- For Expenses, as of Mar 2025, the value is 186.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 187.48 Cr. (Dec 2024) to 186.64 Cr., marking a decrease of 0.84 Cr..
- For Operating Profit, as of Mar 2025, the value is 7.39 Cr.. The value appears to be declining and may need further review. It has decreased from 10.65 Cr. (Dec 2024) to 7.39 Cr., marking a decrease of 3.26 Cr..
- For OPM %, as of Mar 2025, the value is 3.81%. The value appears to be declining and may need further review. It has decreased from 5.38% (Dec 2024) to 3.81%, marking a decrease of 1.57%.
- For Other Income, as of Mar 2025, the value is 21.16 Cr.. The value appears strong and on an upward trend. It has increased from -6.47 Cr. (Dec 2024) to 21.16 Cr., marking an increase of 27.63 Cr..
- For Interest, as of Mar 2025, the value is 18.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.48 Cr. (Dec 2024) to 18.49 Cr., marking a decrease of 0.99 Cr..
- For Depreciation, as of Mar 2025, the value is 11.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.74 Cr. (Dec 2024) to 11.58 Cr., marking a decrease of 0.16 Cr..
- For Profit before tax, as of Mar 2025, the value is -1.52 Cr.. The value appears strong and on an upward trend. It has increased from -27.04 Cr. (Dec 2024) to -1.52 Cr., marking an increase of 25.52 Cr..
- For Tax %, as of Mar 2025, the value is -431.58%. The value appears to be improving (decreasing) as expected. It has decreased from -39.90% (Dec 2024) to -431.58%, marking a decrease of 391.68%.
- For Net Profit, as of Mar 2025, the value is 5.04 Cr.. The value appears strong and on an upward trend. It has increased from -16.25 Cr. (Dec 2024) to 5.04 Cr., marking an increase of 21.29 Cr..
- For EPS in Rs, as of Mar 2025, the value is 4.48. The value appears strong and on an upward trend. It has increased from -3.05 (Dec 2024) to 4.48, marking an increase of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 780 |
| Expenses | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 744 |
| Operating Profit | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 37 |
| OPM % | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 6% | 5% |
| Other Income | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 15 |
| Interest | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 80 |
| Depreciation | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 46 |
| Profit before tax | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -75 |
| Tax % | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | |
| Net Profit | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -51 |
| EPS in Rs | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | -6.96 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.47% | 62.04% | 2.44% | -148.75% | -127.64% | 78.15% | 88.89% | 63.64% | 1350.00% | -218.00% | 5.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 151.51% | -59.60% | -151.19% | 21.11% | 205.78% | 10.74% | -25.25% | 1286.36% | -1568.00% | 223.08% |
Bilcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | -15% |
| 3 Years: | -2% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | -39% |
| 5 Years: | -10% |
| 3 Years: | -5% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:41 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 |
| Inventory Days | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 |
| Days Payable | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 |
| Cash Conversion Cycle | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 |
| Working Capital Days | 114 | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 |
| ROCE % | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Diluted EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Cash EPS (Rs.) | -4.37 | -5.77 | 37.38 | 14.82 | 14.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 161.27 | 68.51 | 69.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 298.99 | 68.51 | 69.74 |
| Revenue From Operations / Share (Rs.) | 334.69 | 317.34 | 416.87 | 358.76 | 264.48 |
| PBDIT / Share (Rs.) | 26.79 | 26.19 | 28.45 | 31.86 | 29.45 |
| PBIT / Share (Rs.) | 7.30 | 7.10 | 12.39 | 15.18 | 10.12 |
| PBT / Share (Rs.) | -30.30 | -30.45 | 83.28 | -1.79 | -10.60 |
| Net Profit / Share (Rs.) | -23.86 | -24.86 | 21.32 | -1.85 | -4.74 |
| NP After MI And SOA / Share (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| PBDIT Margin (%) | 8.00 | 8.25 | 6.82 | 8.87 | 11.13 |
| PBIT Margin (%) | 2.18 | 2.23 | 2.97 | 4.23 | 3.82 |
| PBT Margin (%) | -9.05 | -9.59 | 19.97 | -0.50 | -4.00 |
| Net Profit Margin (%) | -7.12 | -7.83 | 5.11 | -0.51 | -1.79 |
| NP After MI And SOA Margin (%) | -3.65 | -4.44 | 1.53 | -1.49 | -3.38 |
| Return on Networth / Equity (%) | -6.14 | -6.67 | 7.29 | -16.75 | -24.42 |
| Return on Capital Employeed (%) | 1.59 | 1.37 | 2.32 | 4.93 | 3.17 |
| Return On Assets (%) | -2.03 | -2.12 | 0.94 | -1.11 | -1.98 |
| Long Term Debt / Equity (X) | 0.96 | 1.09 | 2.49 | 7.14 | 6.14 |
| Total Debt / Equity (X) | 1.43 | 1.52 | 3.09 | 9.18 | 7.85 |
| Asset Turnover Ratio (%) | 0.52 | 0.47 | 0.72 | 0.43 | 0.29 |
| Current Ratio (X) | 1.01 | 1.17 | 1.01 | 1.04 | 1.08 |
| Quick Ratio (X) | 0.66 | 0.87 | 0.76 | 0.70 | 0.75 |
| Inventory Turnover Ratio (X) | 7.06 | 5.47 | 6.44 | 3.73 | 3.31 |
| Interest Coverage Ratio (X) | 0.76 | 0.75 | 1.12 | 1.09 | 0.91 |
| Interest Coverage Ratio (Post Tax) (X) | 0.39 | 0.36 | -1.94 | 0.51 | 0.49 |
| Enterprise Value (Cr.) | 991.34 | 998.83 | 881.91 | 900.48 | 834.43 |
| EV / Net Operating Revenue (X) | 1.26 | 1.34 | 0.89 | 1.07 | 1.34 |
| EV / EBITDA (X) | 15.72 | 16.20 | 13.16 | 12.01 | 12.03 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| Price / BV (X) | 0.46 | 0.26 | 0.49 | 2.19 | 1.57 |
| Price / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| EarningsYield | -0.13 | -0.25 | 0.14 | -0.07 | -0.15 |
After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Diluted EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.37. This value is below the healthy minimum of 3. It has increased from -5.77 (Mar 24) to -4.37, marking an increase of 1.40.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 334.69. It has increased from 317.34 (Mar 24) to 334.69, marking an increase of 17.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 26.19 (Mar 24) to 26.79, marking an increase of 0.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.10 (Mar 24) to 7.30, marking an increase of 0.20.
- For PBT / Share (Rs.), as of Mar 25, the value is -30.30. This value is below the healthy minimum of 0. It has increased from -30.45 (Mar 24) to -30.30, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -23.86. This value is below the healthy minimum of 2. It has increased from -24.86 (Mar 24) to -23.86, marking an increase of 1.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 2. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For PBDIT Margin (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 10. It has decreased from 8.25 (Mar 24) to 8.00, marking a decrease of 0.25.
- For PBIT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 2.18, marking a decrease of 0.05.
- For PBT Margin (%), as of Mar 25, the value is -9.05. This value is below the healthy minimum of 10. It has increased from -9.59 (Mar 24) to -9.05, marking an increase of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is -7.12. This value is below the healthy minimum of 5. It has increased from -7.83 (Mar 24) to -7.12, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.65. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.65, marking an increase of 0.79.
- For Return on Networth / Equity (%), as of Mar 25, the value is -6.14. This value is below the healthy minimum of 15. It has increased from -6.67 (Mar 24) to -6.14, marking an increase of 0.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 10. It has increased from 1.37 (Mar 24) to 1.59, marking an increase of 0.22.
- For Return On Assets (%), as of Mar 25, the value is -2.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -2.03, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.96, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.43. This value exceeds the healthy maximum of 1. It has decreased from 1.52 (Mar 24) to 1.43, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.47 (Mar 24) to 0.52, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.66, marking a decrease of 0.21.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.06. This value is within the healthy range. It has increased from 5.47 (Mar 24) to 7.06, marking an increase of 1.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.76, marking an increase of 0.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 991.34. It has decreased from 998.83 (Mar 24) to 991.34, marking a decrease of 7.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 15.72. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 15.72, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For Price / BV (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.46, marking an increase of 0.20.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.13. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.13, marking an increase of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bilcare Ltd:
- Net Profit Margin: -7.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.59% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -6.14% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 50.22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 1028, Shiroli, Rajgurunagar, Pune Maharashtra 410505 | cs@bilcare.com www.bilcare.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shreyans Bhandari | Chairman & Managing Director |
| Ms. Kavita Bhansali | Executive Director |
| Mr. Rajesh Devene | Independent Director |
| Mrs. Madhuri Vaidya | Independent Director |
| Ms. Alka Sagar | Independent Director |